bluebird bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLUE research report →
About the company
bluebird bio, Inc. is a biotechnology firm that concentrates on the discovery, development, and commercialization of innovative gene therapies. These pioneering treatments are aimed at debilitating genetic conditions.
- CEO
- Andrew Obenshain
- IPO
- 2013
- Employees
- 248
- HQ
- Cambridge, MA, US
Price Chart
- Market Cap
- $48.67M
- P/E
- -0.20
- P/S
- 0.58
- P/B
- -1.53
- EV/EBITDA
- -2.20
- Div Yield
- 0.00%
- Gross Margin
- -6.65%
- Op Margin
- -322.72%
- Net Margin
- -287.23%
- ROE
- -295.35%
- ROIC
- -82.55%
- Revenue
- $83.81M · 184.12%
- Net Income
- $-240,715,000 · -13.59%
- EPS
- $-24.84 · -736.36%
- Op Income
- $-270,461,000
- FCF YoY
- -7.59%
- 52W High
- $28.60
- 52W Low
- $3.20
- 50D MA
- $4.42
- 200D MA
- $7.51
- Beta
- 0.36
- Avg Volume
- 576.32K
Get TickerSpark's AI analysis on BLUE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 30, 25 | Vittiglio Joseph | other | 1,143 |
| Jun 2, 25 | Vittiglio Joseph | other | 2,500 |
| Jun 2, 25 | Vittiglio Joseph | sell | 2,500 |
| May 30, 25 | Agwunobi John O | other | 1,323 |
| Jun 2, 25 | Agwunobi John O | sell | 1,245 |
| May 30, 25 | Vachon Mark | other | 1,252 |
| Jun 2, 25 | Vachon Mark | sell | 1,245 |
| May 30, 25 | Colvin Richard A | other | 3,552 |
| Jun 2, 25 | Colvin Richard A | other | 2,500 |
| Jun 2, 25 | Colvin Richard A | sell | 2,500 |
Our BLUE coverage
Recent articles, reports, and earnings notes.
No research on BLUE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BLUE report →Similar companies
Peers in the same neighborhood.